Department of Health
and Human Services (HHS)
and Human Services (HHS)
July 29, 2020
PAR-20-136 - Core Infrastructure Support for Cancer Epidemiology Cohorts (U01 Clinical Trial Not Allowed)
National Cancer Institute (NCI)
The purpose of this Notice is to inform interested applicants that the National Cancer Institute (NCI) will terminate PAR-20-136 " Core Infrastructure Support for Cancer Epidemiology Cohorts (U01 Clinical Trial Not Allowed)", effective immediately. NCI will not accept applications in response to PAR-20-136 for the November 9, 2020 submission date.
The following sections of Part 1. Overview Information, Key Dates are being modified:
Currently reads
Application Due Dates(s): April 7, 2020; November 9, 2020; April 9, 2021; November 9, 2021; April 7, 2022; November 9, 2022
Modified to read
Application Due Dates(s): April 7, 2020
Currently reads
Scientific Merit Review: June/July 2020; February/March 2021; June/July 2021; February/March 2022; June/July 2022; February/March 2023
Modified to read
Scientific Merit Review: June/July 2020
Currently reads
Advisory Council Review: October 2020; May 2021; October 2021; May 2022; October 2022; May 2023
Modified to read
Advisory Council Review: October 2020
Currently reads
Earliest Start Date: January 2021; July 2021; January 2022; July 2022; January 2023; July 2023
Modified to read
Earliest Start Date: January 2021
Currently reads
Expiration Date: November 10, 2022
Modified to read
Expiration Date: July 30, 2020
All other aspects of PAR-20-136 remain unchanged.
Scientific/Research Contact(s)
Joanne Elena, PhD, MPH
National Cancer Institute (NCI)
Telephone: 240-276-6818
Email: [email protected]
Peer Review Contact(s)
Referral Officer
National Cancer Institute (NCI)
Telephone: 240-276-6390
Email: [email protected]